A 39-year:old man presented with a lO-day history of left-sided epistaxis, facial pain, pressure, and nasal congestion. He failed to respond to antibiotic therapy prescribed by his internist. He denied any vision changes. He had a 25-pack-year smoking history and a history of heavy alcohol and illicit drug use. Physical examination demonstrated mild left proptosis; findings on the remainder of the eye examination were normal. Nasopharyngolaryngoscopy detected a smooth mass emanating from the left middle meatus. The remainder of the head and neck findings were within normal limits.
Clinical manifestations of sinonasal undifferentiated carcinoma
Hootan Zandifar, MD; Jason S. Hamilton, MD; Ryan F. Osborne, MD; Robert M. Kellman, MD A 39-year:old man presented with a lO-day history of left-sided epistaxis, facial pain, pressure, and nasal congestion. He failed to respond to antibiotic therapy prescribed by his internist. He denied any vision changes. He had a 25-pack-year smoking history and a history of heavy alcohol and illicit drug use. Physical examination demonstrated mild left proptosis; findings on the remainder of the eye examination were normal. Nasopharyngolaryngoscopy detected a smooth mass emanating from the left middle meatus. The remainder of the head and neck findings were within normal limits.
Computed tomography (CT) of the sinuses demonstrated a large, enhancing mass within the left ethmoid sinus; CT also showed tumor erosion through the anterior cranial fossa and the left lamina papyracea and compression of the medial rectus muscle and optic nerve (figure 1). Magnetic resonance imaging (MRI) of the head confirmed that the lesion was a homogeneously enhancing mass within the left ethmoid sinus; MRI also showed the extension through the anterior cranial fossa and the left medial orbital wall (figure 2). Findings on nasoendoscopic biopsy of the mass were consistent with sinonasal undifferentiated carcinoma (SNUC) ( figure 3 ). The patient was treated with intensity-modulated radiation therapy concomitant with chemotherapy, followed by craniofacial resection and free-tissue graft reconstruction. Surgical pathology revealed no evidence of viable tumor. At the 4-year follow-up, the patient was alive and free of disease.
Tumors of the sinonasal tract constitute 3% of all head and neck malignancies. Of these, squamous cell carcinoma is the most common histologic type. SNUC is a rare and highly aggressive malignancy of the nasal cavity and paranasal sinuses. It was first described in 1986 by Frierson et al. ' Patients with SNUC typically pr~sent with epistaxis, nasal congestion, sinus pressure, bloody rhinorrhea, and ophthalmologic findings such as diplopia. As a result, these patients are often treated for sinusitis or rhinitis. Only when symptoms worsen are they referred for further workup.i" SNUC has a reported predilection for males, with a male -to-female ratio of approximately 3:1,203 The most common specific site of origin is the nasal cavity, followed by the ethmoid sinuses. Orbital or cranial extension is common at the time of diagnosis. Approximately 1 in 6 patients presents with a cervical lymph node metastasis, and 1 in 3 has been found to have a distant metastasis to, for example, the liver, lungs, or bone.'
CT and MRI are both important tool s in delineating th e direct extension of the disease and the destruction to sur rounding structures. CT typically shows a large, moderately enhancing tumor with poorly defined margins, destruction of the surrounding bone, and invasion of adjacent structures. MRI will show a heterogeneously enhancing tumor th at is isointense with mu scle on Tl-weighted imaging and iso-to hyperintense on T2-weighted imaging.'
Histopathologically, SNUC shares some similarities with nasopharyngeal carcinoma and squamous cell carcinoma. However, there are also some distinct differences, indicating th at SNUC is a separate ent ity. Histologically, SNUC shows small to medium-sized cells with large ovoid nuclei and a high nucleus-tocytop lasm ratio. The cells may be arranged in sheets, nests, trabeculae, and ribbons. A high number of m itotic figures is present, and the tumor shows extensive coagulative necrosis with areas of central comedonecrosis. A single prominent nucleolus is typically present . The high-grade nuclei in SNUC cells are relatively uniform, unlike those in nasopharyngeal carcinoma, which show a high degree of internuclear variability.' Special techniques such as Ki-67 staining and immunohistochemistry studies for cytokeratin subtypes CKS, CK7, and CK19 might guide in pathologically differentiating SNUC from nasopharyngeal carcinoma and squamous cell carcinorna.Y . To assist in formulating a prognosis, Miyamoto et al developed a staging system based on the Hyams pathologic grading system and the Kadish staging system for esthesioneuroblastoma.' Both systems independently predict ou tcomes . Although early case series showed a poor l -year surv ival rate (9%) , recent advancements in chemotherapy, radiation on cology, and surgica l 125 4 · www .entjournal.com Figure3. Pathologicstudyof the initialbiopsy specimen at different magnificationsrevealssmall to medium-sized cellswith large ovoid nuclei and with a high nucleus-to-cytoplasm ratio arranged in a trabecularpattern.
techniques have imp roved these results.v'" Longer survival has been seen with aggressive multimodality therapy that includes th e incorporation of complete sur gical resection, chemotherapy, and radiotherapy." SNUC is a distinct and aggressive entity th at should be diagnosed early and treated aggressively.
